|
(1) Aguirre-Crespo, F., Vergara-Galicia, J., Villalobos-Molina, R., Javier Lopez-Guerrero, J., Navarrete-Vazquez, G., and Estrada-Soto, S. (2006). Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta. Life Sci 79, 1062-1068.
(2) Ali, M.S., Ibrahim, S.A., Jalil, S., and Choudhary, M.I. (2007). Ursolic acid: a potent inhibitor of superoxides produced in the cellular system. Phytother Res 21, 558-561.
(3) Andersson, U., Erlandsson-Harris, H., Yang, H., and Tracey, K.J. (2002). HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72, 1084-1091.
(4) Aramaki, Y., Mitsuoka, H., Toyohara, M., Jinnai, T., Kanatani, K., Nakajima, K., Mukai, E., Yamada, Y., Kita, T., Inagaki, N., and Kume, N. (2008). Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis 198, 272-279.
(5) Ardans, J.A., Economou, A.P., Martinson, J.M., Jr., Zhou, M., and Wahl, L.M. (2002). Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J Leukoc Biol 71, 1012-1018.
(6) Autieri, M.V., Carbone, C., and Mu, A. (2000). Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler Thromb Vasc Biol 20, 1737-1744.
(7) Autieri, M.V., Kelemen, S., Thomas, B.A., Feller, E.D., Goldman, B.I., and Eisen, H.J. (2002). Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 106, 2218-2223.
(8) Balanehru, S., and Nagarajan, B. (1991). Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int 24, 981-990.
(9) Bolz, S.S., and Pohl, U. (1997). Indomethacin enhances endothelial NO release--evidence for a role of PGI2 in the autocrine control of calcium-dependent autacoid production. Cardiovasc Res 36, 437-444.
(10) Boullier, A., Bird, D.A., Chang, M.K., Dennis, E.A., Friedman, P., Gillotre-Taylor, K., Horkko, S., Palinski, W., Quehenberger, O., Shaw, P., Steinberg, D., Terpstra, V., and Witztum, J.L. (2001). Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 947, 214-222
(11) Cardenas, C., Quesada, A.R., and Medina, M.A. (2004). Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun 320, 402-408.
(12) Chen, J., Liu, Y., Liu, H., Hermonat, P.L., and Mehta, J.L. (2006a). Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochem J 393, 255-265.
(13) Chen, J.Z., Zhu, J.H., Wang, X.X., Zhu, J.H., Xie, X.D., Sun, J., Shang, Y.P., Guo, X.G., Dai, H.M., and Hu, S.J. (2004). Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36, 233-239.
(14) Chen, Y.L., Hu, C.S., Lin, F.Y., Chen, Y.H., Sheu, L.M., Ku, H.H., Shiao, M.S., Chen, J.W., and Lin, S.J. (2006b). Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J Cell Biochem 98, 618-631.
(15) Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G., and Bianchi, M.E. (2001). The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152, 1197-1206.
(16) Elewa, H.F., El-Remessy, A.B., Somanath, P.R., and Fagan, S.C. (2010). Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy 30, 169-176.
(17) Escribano, M., Molero, L., Lopez-Farre, A., Abarrategui, C., Carrasco, C., Garcia-Mendez, A., Manzarbeitia, F., Martin, M.J., Vazquez, M., Sanchez-Fayos, P., Rico, L., and Porres Cubero, J.C. (2004). Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development. Clin Sci (Lond) 106, 83-91.
(18) Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J.H., and Suffredini, A.F. (2003). Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101, 2652-2660.
(19) Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S., and Otomo, S. (1993). Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol 45, 753-755.
(20) Germani, A., Limana, F., and Capogrossi, M.C. (2007). Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair. J Leukoc Biol 81, 41-45.
(21) Gigante, B., Morlino, G., Gentile, M.T., Persico, M.G., and De Falco, S. (2006). Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. Faseb J 20, 970-972.
(22) Goldin, A., Beckman, J.A., Schmidt, A.M., and Creager, M.A. (2006). Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114, 597-605.
(23) Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
(24) Hayashida, K., Kume, N., Minami, M., Inui-Hayashida, A., Mukai, E., Toyohara, M., and Kita, T. (2004). Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif. Biochem Biophys Res Commun 323, 1116-1123.
(25) Hayden, B.J., and Balen, A.H. (2006). The role of the central nervous system in the pathogenesis of polycystic ovary syndrome. Minerva Ginecol 58, 41-54.
(26) Hofnagel, O., Luechtenborg, B., Eschert, H., Weissen-Plenz, G., Severs, N.J., and Robenek, H. (2006). Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins. Arterioscler Thromb Vasc Biol 26, 604-610.
(27) Hofnagel, O., Luechtenborg, B., Stolle, K., Lorkowski, S., Eschert, H., Plenz, G., and Robenek, H. (2004). Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24, 1789-1795.
(28) Hu, C., Dandapat, A., Sun, L., Chen, J., Marwali, M.R., Romeo, F., Sawamura, T., and Mehta, J.L. (2008). LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 79, 287-293.
(29) Huang, W., Liu, Y., Li, L., Zhang, R., Liu, W., Wu, J., Mao, E., and Tang, Y. (2012). HMGB1 Increases Permeability of the Endothelial Cell Monolayer via RAGE and Src Family Tyrosine Kinase Pathways. Inflammation 35, 350-362.
(30) Ikeda, Y., Murakami, A., and Ohigashi, H. (2008). Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 52, 26-42.
(31) Imai, Y., Ibata, I., Ito, D., Ohsawa, K., and Kohsaka, S. (1996). A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 224, 855-862.
(32) Imai, Y., and Kohsaka, S. (2002). Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40, 164-174.
(33) Jia, J., Cai, Y., Wang, R., Fu, K., and Zhao, Y.F. (2010). Overexpression of allograft inflammatory factor-1 promotes the proliferation and migration of human endothelial cells (HUV-EC-C) probably by up-regulation of basic fibroblast growth factor. Pediatr Res 67, 29-34.
(34) Jie Xue, M.X., Zhenlun Gu (2006). Mechanisms for Regulating Cholesterol Metabolism by Protocatechualdehyde, Ursolic acid and Quercetin. Asia J Trad Med 1, 60-63
(35) Kalinina, N., Agrotis, A., Antropova, Y., DiVitto, G., Kanellakis, P., Kostolias, G., Ilyinskaya, O., Tararak, E., and Bobik, A. (2004). Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 24, 2320-2325.
(36) Kanjoormana, M., and Kuttan, G. (2010). Antiangiogenic activity of ursolic acid. Integr Cancer Ther 9, 224-235.
(37) Kim, J., Jang, D.S., Kim, H., and Kim, J.S. (2009). Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta. Arch Pharm Res 32, 983-987.
(38) Kimura, M., Kawahito, Y., Obayashi, H., Ohta, M., Hara, H., Adachi, T., Tokunaga, D., Hojo, T., Hamaguchi, M., Omoto, A., Ishino, H., Wada, M., Kohno, M., Tsubouchi, Y., and Yoshikawa, T. (2007). A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 178, 3316-3322.
(39) Kiran, M.S., Viji, R.I., Sameer Kumar, V.B., and Sudhakaran, P.R. (2008). Modulation of angiogenic factors by ursolic acid. Biochem Biophys Res Commun 371, 556-560.
(40) Kukreja, R.C., and Xi, L. (2007). eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection? J Mol Cell Cardiol 42, 280-282.
(41) Lacza, Z., Dezsi, L., Kaldi, K., Horvath, E.M., Sandor, P., and Benyo, Z. (2003). Prostacyclin-mediated compensatory mechanism in the coronary circulation during acute NO synthase blockade. Life Sci 73, 1141-1149.
(42) Landsman, D., and Bustin, M. (1993). A signature for the HMG-1 box DNA-binding proteins. Bioessays 15, 539-546.
(43) Leth, T., Jensen, H.G., Mikkelsen, A.A., and Bysted, A. (2006). The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 7, 53-56.
(44) Li, D., Liu, L., Chen, H., Sawamura, T., Ranganathan, S., and Mehta, J.L. (2003a). LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 107, 612-617.
(45) Li, D., and Mehta, J.L. (2000). Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20, 1116-1122.
(46) Li, D., Singh, R.M., Liu, L., Chen, H., Singh, B.M., Kazzaz, N., and Mehta, J.L. (2003b). Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc Res 57, 238-243.
(47) Li, H., and Forstermann, U. (2009a). Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15, 3133-3145.
(48) Li, L., and Renier, G. (2009b). The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis 204, 40-46.
(49) Li, L., Sawamura, T., and Renier, G. (2004). Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 94, 892-901.
(50) Li, Y., Kang, Z., Li, S., Kong, T., Liu, X., and Sun, C. (2010a). Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes. Mol Nutr Food Res.
(51) Li, Y., Kang, Z., Li, S., Kong, T., Liu, X., and Sun, C. (2010b). Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes. Mol Nutr Food Res 54, 1609-1617.
(52) Lin, F.Y., Lin, Y.W., Huang, C.Y., Chang, Y.J., Tsao, N.W., Chang, N.C., Ou, K.L., Chen, T.L., Shih, C.M., and Chen, Y.H. (2011). GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits. J Immunol 186, 4405-4414.
(53) Liu, Y., Tian, W., Ma, X., and Ding, W. (2010). Evaluation of inhibition of fatty acid synthase by ursolic acid: positive cooperation mechanism. Biochem Biophys Res Commun 392, 386-390.
(54) Lu, J., Zheng, Y.L., Wu, D.M., Luo, L., Sun, D.X., and Shan, Q. (2007). Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochem Pharmacol 74, 1078-1090.
(55) Lv, B., Wang, H., Tang, Y., Fan, Z., Xiao, X., and Chen, F. (2009). High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost 102, 352-359.
(56) Melvin, V.S., and Edwards, D.P. (1999). Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 64, 576-586.
(57) Merenmies, J., Pihlaskari, R., Laitinen, J., Wartiovaara, J., and Rauvala, H. (1991). 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 266, 16722-16729.
(58) Mizock, B.A., and Falk, J.L. (1992). Lactic acidosis in critical illness. Crit Care Med 20, 80-93.
(59) Najid, A., Simon, A., Cook, J., Chable-Rabinovitch, H., Delage, C., Chulia, A.J., and Rigaud, M. (1992). Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett 299, 213-217.
(60) Noll, C., Hamelet, J., Matulewicz, E., Paul, J.L., Delabar, J.M., and Janel, N. (2009). Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. J Nutr Biochem 20, 586-596.
(61) Oh, C.J., Kil, I.S., Park, C.I., Yang, C.H., and Park, J.W. (2007). Ursolic acid regulates high glucose-induced apoptosis. Free Radic Res 41, 638-644.
(62) Palumbo, R., Sampaolesi, M., De Marchis, F., Tonlorenzi, R., Colombetti, S., Mondino, A., Cossu, G., and Bianchi, M.E. (2004). Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 164, 441-449.
(63) Pedrazzi, M., Patrone, M., Passalacqua, M., Ranzato, E., Colamassaro, D., Sparatore, B., Pontremoli, S., and Melloni, E. (2007). Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol 179, 8525-8532.
(64) Ramachandran, S., and Prasad, N.R. (2008). Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem Biol Interact 176, 99-107.
(65) Ringbom, T., Segura, L., Noreen, Y., Perera, P., and Bohlin, L. (1998). Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis. J Nat Prod 61, 1212-1215.
(66) Sachdev, U., Cui, X., Hong, G., Namkoong, S., Karlsson, J.M., Baty, C.J., and Tzeng, E. (2012). High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury. J Vasc Surg 55, 180-191.
(67) Saravanan, R., Viswanathan, P., and Pugalendi, K.V. (2006). Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci 78, 713-718.
(68) Sata, M. (2002). Biphasic effects of statins on angiogenesis. Circulation 106, e47; author reply e47.
(69) Searles, C.D., Ide, L., Davis, M.E., Cai, H., and Weber, M. (2004). Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res 95, 488-495.
(70) Shishodia, S., Majumdar, S., Banerjee, S., and Aggarwal, B.B. (2003). Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63, 4375-4383.
(71) Smirnova, I.V., Sawamura, T., and Goligorsky, M.S. (2004). Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in endothelial cells by nitric oxide deficiency. Am J Physiol Renal Physiol 287, F25-32.
(72) Sohn, K.H., Lee, H.Y., Chung, H.Y., Young, H.S., Yi, S.Y., and Kim, K.W. (1995). Anti-angiogenic activity of triterpene acids. Cancer Lett 94, 213-218.
(73) Sommerville, L.J., Kelemen, S.E., and Autieri, M.V. (2008). Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice. Arterioscler Thromb Vasc Biol 28, 47-53.
(74) Steinkamp-Fenske, K., Bollinger, L., Voller, N., Xu, H., Yao, Y., Bauer, R., Forstermann, U., and Li, H. (2007). Ursolic acid from the Chinese herb danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells. Atherosclerosis 195, e104-111.
(75) Su, Y., Edwards-Bennett, S., Bubb, M.R., and Block, E.R. (2003). Regulation of endothelial nitric oxide synthase by the actin cytoskeleton. Am J Physiol Cell Physiol 284, C1542-1549.
(76) Subbaramaiah, K., Michaluart, P., Sporn, M.B., and Dannenberg, A.J. (2000). Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 60, 2399-2404.
(77) Suh, N., Honda, T., Finlay, H.J., Barchowsky, A., Williams, C., Benoit, N.E., Xie, Q.W., Nathan, C., Gribble, G.W., and Sporn, M.B. (1998). Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58, 717-723.
(78) Takemura, N.U., and Kato, N. (2008). Adult neurogenesis and systemic adaptation: animal experiments and clinical perspectives for PTSD. Prog Brain Res 167, 99-109.
(79) Thum, T., and Borlak, J. (2008). LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. J Biol Chem 283, 19456-19464.
(80) Tian, Y., Jain, S., Kelemen, S.E., and Autieri, M.V. (2009). AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis. Am J Physiol Cell Physiol 296, C256-266.
(81) Tian, Y., Kelemen, S.E., and Autieri, M.V. (2006). Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli. Am J Physiol Cell Physiol 290, C1083-1091.
(82) Timoshenko, A.V., Lala, P.K., and Chakraborty, C. (2004). PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. Int J Cancer 108, 384-389.
(83) Tsai, S.J., and Yin, M.C. (2008). Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells. J Food Sci 73, H174-178.
(84) Tsukamoto, K., Kinoshita, M., Kojima, K., Mikuni, Y., Kudo, M., Mori, M., Fujita, M., Horie, E., Shimazu, N., and Teramoto, T. (2002). Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J Atheroscler Thromb 9, 57-64.
(85) Utans, U., Arceci, R.J., Yamashita, Y., and Russell, M.E. (1995). Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 95, 2954-2962.
(86) Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K.R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P.E., Abumrad, N.N., Sama, A., and Tracey, K.J. (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
(87) Weis, M., Heeschen, C., Glassford, A.J., and Cooke, J.P. (2002). Statins have biphasic effects on angiogenesis. Circulation 105, 739-745.
(88) Yamada, S., and Maruyama, I. (2007). HMGB1, a novel inflammatory cytokine. Clin Chim Acta 375, 36-42.
(89) Yamada, S., Yakabe, K., Ishii, J., Imaizumi, H., and Maruyama, I. (2006). New high mobility group box 1 assay system. Clin Chim Acta 372, 173-178.
(90) Yan, S.L., Huang, C.Y., Wu, S.T., and Yin, M.C. (2010). Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol In Vitro 24, 842-848.
(91) Yao, E.H., Fukuda, N., Ueno, T., Matsuda, H., Matsumoto, K., Nagase, H., Matsumoto, Y., Takasaka, A., Serie, K., Sugiyama, H., and Sawamura, T. (2008). Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury. Hypertension 52, 86-92.
(92) Yin, M.C., and Chan, K.C. (2007). Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J Agric Food Chem 55, 7177-7181.
(93) You, H.J., Choi, C.Y., Kim, J.Y., Park, S.J., Hahm, K.S., and Jeong, H.G.
(2001). Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett 509, 156-160.
(94) Yu, Y.H., Wang, Y., Dong, B., Sun, S.Z., Chen, Y., Meng, X.H., and Liu, Z.Z. (2005). Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia. Chin Med J (Engl) 118, 621-626.
(95) Zheng, Z.J., Folsom, A.R., Ma, J., Arnett, D.K., McGovern, P.G., and Eckfeldt, J.H. (1999). Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 150, 492-500.
|